In addition, other studies have claimed that SETBP1 expression is associated with acute myeloid leukemia and that microRNA-211-5p directly targets SETBP1 to inhibit triple-negative breast cancer cell proliferation, migration and metastasis (Chen et al., 2017). Here, SETBP1 is linked to triple-negative breast carcinoma.